CompletedNCT03573297
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Malaysia, Poland, United States, Russian Federation, Serbia, South Korea, Taiwan, Thailand, Ukraine
- Sponsor
- AbbVie
- Condition
- Bipolarity
CompletedNCT04191876
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
CompletedNCT03679962
This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 12 Years to 17 Years
- Countries
- United States
- Sponsor
- Billings Clinic
- Condition
- Depression
CompletedNCT01342380
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
DepressionOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- University Hospitals Cleveland Medical Center
- Condition
- Depression
CompletedNCT01065597
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Maryland, College Park
- Condition
- Depression
CompletedNCT03543410
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Japan, Poland, Russian Federation, Serbia, Slovakia, Ukraine, United States
- Sponsor
- Sumitomo Pharma America, Inc.
- Condition
- Depression
CompletedNCT02600507
This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand how people respond to the medication ITI-007 in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 75 Years
- Countries
- Bulgaria, Russian Federation, Serbia, Ukraine, United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Bipolarity
CompletedNCT01881763
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Depression
CompletedNCT03049813
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Michigan
- Condition
- Schizophrenia
CompletedNCT02567110
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 35 Years to 65 Years
- Countries
- United States
- Sponsor
- Emory University
- Condition
- Depression
CompletedNCT02188121
This study exists to understand how the medication New holds up over time after the earliest research stage. Researchers are trying to understand what helps the medication New stay useful, realistic, and easier to follow over time.
SchizophreniaOtherFrom 18 Years to 89 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Schizophrenia
CompletedNCT05683431
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 30 Years
- Countries
- United States
- Sponsor
- Rush University Medical Center
- Condition
- Bipolarity
CompletedNCT02558075
This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Michigan
- Condition
- Bipolarity
CompletedNCT03423212
This study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 28 Years
- Countries
- United States
- Sponsor
- New York University
- Condition
- Bipolarity
CompletedNCT05601063
This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 14 Years to 50 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
CompletedNCT02696109
This study exists to see whether acceptance and commitment therapy, a talking treatment, is workable and worth testing more broadly. Researchers are trying to understand how people respond to acceptance and commitment therapy, a talking treatment, in practice and what may need to be adjusted.
BipolarityOtherFrom 17 Years to 18 Years
- Countries
- United States
- Sponsor
- New York University
- Condition
- Bipolarity
CompletedNCT01992393
This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Case Western Reserve University
- Condition
- Schizophrenia
CompletedNCT03402152
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
- Condition
- Bipolarity
CompletedNCT01880957
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Stony Brook University
- Condition
- Bipolarity
CompletedNCT03249376
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 75 Years
- Countries
- Bulgaria, Colombia, Russian Federation, Serbia, Ukraine, United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Bipolarity
CompletedNCT02640950
This study exists to understand whether the medication TMS is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication TMS can give earlier or clearer feedback during care.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Sheppard Pratt Health System
- Condition
- Bipolarity
WithdrawnNCT04430959
This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Bipolarity
CompletedNCT02845440
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand how people respond to smoking support or smoking-related treatment in practice and what may need to be adjusted.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Depression
CompletedNCT03156504
This study exists to see whether the medication Ketamine can play a useful role in care. Researchers are trying to understand whether the medication Ketamine can better support energy, concentration, and everyday functioning.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Bipolarity
TerminatedNCT02707276
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 55 Years to 85 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Bipolarity